RBM20 and nervous system disorder: Hence, these data strongly support a model by which mutant RBM20 impacts alternative splicing through broad non-nuclear 3′ UTR binding and association with P-bodies, a mechanism that is reminiscent of neurological diseases associated with RNA-binding protein cytoplasmic aggregation (Fig. 6).